The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients
Tetsuya Toge(Hiroshima University), Takao Hattori(Hiroshima University), Nobutoshi Baba(Hiroshima University), Yoshiyuki Yamaguchi(Hiroshima University), H Kuninobu(Hiroshima University), Yasuhide Kegoya(Hiroshima University)
Cited by 6
Related Papers
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
Targeted therapy against Bcl-2-related proteins in breast cancer cells
|Breast Cancer Research|2005|114
Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice
|International Journal of Cancer|1992|111